Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FLUCICLOVINE F-18
- 18F-Fluciclovine PET/CT in Multiple Myeloma
- Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
- 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
- Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET
- Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
- Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
- 18F-Fluciclovine PET-MRI in High-grade Glioma
- 18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy
- Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
- 18F-Fluciclovine PET/CT in the Assessment of Pancreatic Transplants
- Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
- Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
- Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
- Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study
- Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Using PET/CT Imaging
- Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)
- Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases
- Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand
- Fluciclovine (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
- 18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies
- An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer
- Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma
- 18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
- [18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
- 18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation Necrosis
- 18F-Fluciclovine PET and Multiparametric MR Imaging
- Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes
- Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone
- Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery
- Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.
- A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer
- Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.
- [18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
- Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI
- High Resolution PET-MRI Before Prostate Cancer HIFU
- Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease
- FACBC Prostate Therapy Response
- 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment
- Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer
- FACBC PET/CT for Recurrent Prostate Cancer
Clinical trials list
click for details